pubmed-article:8102883 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0185115 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0037633 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C1382100 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0599956 | lld:lifeskim |
pubmed-article:8102883 | lifeskim:mentions | umls-concept:C0053163 | lld:lifeskim |
pubmed-article:8102883 | pubmed:issue | 4-5 | lld:pubmed |
pubmed-article:8102883 | pubmed:dateCreated | 1993-9-30 | lld:pubmed |
pubmed-article:8102883 | pubmed:abstractText | The use of phenylboronic acid (PBA) solid-phase extraction cartridges for the extraction of a range of beta-blockers from aqueous buffer and plasma has been investigated and compared with other phases commonly used for solid-phase extraction. PBA was found to provide an efficient means for the extraction of this class of compound from simple aqueous buffer systems. Extraction from buffers was pH-dependent and gave optimum results at approximately pH 8. Extraction from plasma was less efficient for some of the test compounds; this matrix effect was probably due to protein binding. Chromatography showed that plasma extracts were free of major sources of interference. | lld:pubmed |
pubmed-article:8102883 | pubmed:language | eng | lld:pubmed |
pubmed-article:8102883 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8102883 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8102883 | pubmed:issn | 0731-7085 | lld:pubmed |
pubmed-article:8102883 | pubmed:author | pubmed-author:WilsonI DID | lld:pubmed |
pubmed-article:8102883 | pubmed:author | pubmed-author:MartinPP | lld:pubmed |
pubmed-article:8102883 | pubmed:author | pubmed-author:LeadbetterBB | lld:pubmed |
pubmed-article:8102883 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8102883 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:8102883 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8102883 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8102883 | pubmed:pagination | 307-12 | lld:pubmed |
pubmed-article:8102883 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:meshHeading | pubmed-meshheading:8102883-... | lld:pubmed |
pubmed-article:8102883 | pubmed:articleTitle | Immobilized phenylboronic acids for the selective extraction of beta-blocking drugs from aqueous solution and plasma. | lld:pubmed |
pubmed-article:8102883 | pubmed:affiliation | Department of Safety of Medicines, ICI Pharmaceuticals, Alderly Park, Macclesfield, UK. | lld:pubmed |
pubmed-article:8102883 | pubmed:publicationType | Journal Article | lld:pubmed |